Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.92−2.76 (-16.55%)
Close on Nov 17, 2026Market cap $1.01BP/E –Yield –
Omeros price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Omeros's price to sales ratio was 5.3× on Jan 31, 2022, against 12.4× a year earlier. Over the last 5 years it ranged from 5.3× to 32.5×, with a median of 13.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jan 31, 2022 | 5.3× | −0.4 |
| 2021 | Dec 31, 2021 | 5.6× | −3.5 |
| 2020 | Dec 31, 2020 | 9.1× | +2.2 |
| 2019 | Dec 31, 2019 | 7.0× | −18.3 |
| 2018 | Dec 31, 2018 | 25.3× | +10.7 |
| 2017 | Dec 29, 2017 | 14.6× | +2.5 |
| 2016 | Dec 30, 2016 | 12.0× | −73.1 |
| 2015 | Dec 31, 2015 | 85.2× | −149.8 |
| 2014 | Apr 30, 2014 | 234.9× | +123.1 |
| 2013 | Dec 31, 2013 | 111.8× | +87.7 |
| 2012 | Dec 31, 2012 | 24.1× | +3.8 |
| 2011 | Dec 30, 2011 | 20.2× | – |
See a number that looks wrong?